ALEXANDRIA HASTINGS: Open Payments
NPI 1588323901 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 37 payments from 8 companies in 2025. Trend: 2023 $319 · 2024 $1,132 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $148 |
| ABBVIE INC. | 8 | $145 |
| CORDIS US CORP. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Novo Nordisk Inc | 3 | $66 |
| PFIZER INC. | 3 | $58 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Amgen Inc. | 1 | $14 |
Products named: UBRELVY, MYNX CONTROL VENOUS, LEQVIO, Wegovy, ELIQUIS, AVVIGO Guidance System, General - Balloon Catheters, QULIPTA.
Industry payments across NV — which companies pay providers there.
